134380 — Miwon Chemicals Co Balance Sheet
0.000.00%
- KR₩159bn
- KR₩110bn
- KR₩256bn
- 86
- 92
- 47
- 89
Annual balance sheet for Miwon Chemicals Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 7,653 | 6,595 | 12,962 | 26,540 | 48,546 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 19,337 | 29,910 | 29,978 | 36,874 | 36,566 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 39,991 | 54,075 | 62,838 | 80,680 | 105,312 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 81,692 | 75,696 | 81,215 | 79,802 | 77,818 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 125,336 | 133,843 | 147,864 | 164,771 | 187,153 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5,374 | 5,401 | 6,792 | 12,114 | 15,056 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 12,431 | 13,888 | 15,155 | 20,282 | 24,782 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 112,905 | 119,955 | 132,709 | 144,489 | 162,371 |
Total Liabilities & Shareholders' Equity | 125,336 | 133,843 | 147,864 | 164,771 | 187,153 |
Total Common Shares Outstanding |